Get App Open
In App
Lending
Lending
Open App
you are here:

Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE010B01027 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 17, 16:01
987.30 3.30 (0.34%)
Volume
AVERAGE VOLUME
5-Day
24,500
10-Day
32,482
30-Day
38,226
33,547
  • Prev. Close

    984.00

  • Open Price

    977.75

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 17, 15:56
987.65 3.05 (0.31%)
Volume
AVERAGE VOLUME
5-Day
902,091
10-Day
975,994
30-Day
951,534
745,052
  • Prev. Close

    984.60

  • Open Price

    984.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    987.65 (166)

Financials

Profit & Loss account of Zydus Lifesciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 14,590.10 10,317.60 8,421.20 7,590.00 7,436.70  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 14,590.10 10,317.60 8,421.20 7,590.00 7,436.70  
Total Operating Revenues 15,116.30 10,818.70 8,731.60 7,981.90 7,780.00  
Other Income 696.20 1,084.80 548.40 178.70 89.30  
Total Revenue 15,812.50 11,903.50 9,280.00 8,160.60 7,869.30  
EXPENSES  
Cost Of Materials Consumed 2,787.10 3,001.40 2,703.50 2,629.00 2,346.40  
Purchase Of Stock-In Trade 350.90 283.20 362.70 288.10 153.30  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -121.10 -131.70 105.10 -46.90 -148.30  
Employee Benefit Expenses 1,762.20 1,507.50 1,321.90 1,204.90 1,147.30  
Finance Costs 463.90 390.70 278.20 134.90 70.90  
Depreciation And Amortisation Expenses 523.90 504.40 488.60 478.70 451.10  
Other Expenses 2,600.90 2,099.60 1,784.00 1,988.70 1,972.60  
Total Expenses 8,367.80 7,655.10 7,044.00 6,677.40 5,993.30  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 7,444.70 4,248.40 2,236.00 1,483.20 1,876.00  
Exceptional Items 0.00 -8.60 -203.80 -319.30 -187.50  
Profit/Loss Before Tax 7,444.70 4,239.80 2,032.20 1,163.90 1,688.50  
Tax Expenses-Continued Operations  
Current Tax 1,582.50 934.30 461.80 260.20 303.30  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 87.30 -136.00 41.20 45.80 -91.00  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 1,669.80 798.30 503.00 306.00 212.30  
Profit/Loss After Tax And Before ExtraOrdinary Items 5,774.90 3,441.50 1,529.20 857.90 1,476.20  
Profit/Loss From Continuing Operations 5,774.90 3,441.50 1,529.20 857.90 1,476.20  
Profit/Loss For The Period 5,774.90 3,441.50 1,529.20 857.90 1,476.20  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 57.39 34.01 15.06 8.38 14.42  
Diluted EPS (Rs.) 57.39 34.01 15.06 8.38 14.42  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 301.90 607.30 253.00 358.50 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 1,100.00 300.00 600.00 250.00 350.00  
Source : Dion Global Solutions Limited

Results of Zydus Life

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970